Recordati reported EUR497.97M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Almirall EUR 429.87M 180.02M Dec/2025
GlaxoSmithKline GBP 6.51B 757M Jun/2026
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Orion EUR 339.9M 85.9M Jun/2026
Sanofi EUR 8.71B 602M Jun/2026